Methylglyoxal reduces cell viability and mitochondrion membrane potential of human brain microvascular endothelial cell line hCMEC/D3

doi:10.16352/j.issn.1001-6325.2023.11.1631

Basic & Clinical Medicine ›› 2023, Vol. 43 ›› Issue (11): 1631-1635.doi: 10.16352/j.issn.1001-6325.2023.11.1631

• Original Articles • Next Articles

Methylglyoxal reduces cell viability and mitochondrion membrane potential of human brain microvascular endothelial cell line hCMEC/D3

LI Tingting¹, HAN Zhenping², GAO Li¹, WANG Siyi², ZHONG Kai¹, HUANG Ping^1,3, YAN Jieping^1,3*

1. Center for Clinical Pharmacy, Department of Pharmacy, Zhejiang Provincial People's Hospital, People's Hospital Affiliated to Hangzhou Medical College, Hangzhou 310014;
2. Department of Pharmacology, College of Pharmaceutical Sciences,Zhejiang University of Technology, Hangzhou 310014;
3. Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou 310014, China

Received:2023-02-07 Revised:2023-07-18 Online:2023-11-05 Published:2023-10-30
Contact: ^*yanjieping@hmc.edu.cn

Abstract

Abstract: Objective To explore the effects and mechanism of methylglyoxal (MGO) in human brain microvascular endothelial cell line (hCMEC/D3). Methods The hCMEC/D3 cells were incubated with MGO(0.25, 0.50, 0.75, 1.00 and 1.25 mmol/L) for 24 h. Cell viability was detected by CCK-8 assay. Cellular LDH and SOD activities were determined by commercially available kits. The change of mitochondrion membrane potential was assessed by JC-1 probe. MitoSOX probe was used to observe mitochondrial reactive oxygen species (mROS) release. Results Compared with control, cell viability of hCMEC/D3 treated with MGO decreased in a concentration-dependent manner (P＜0.01). Increased LDH activity and decreased SOD activity were observed with MGO exposure(P＜0.01). The decrease of mitochondrion membrane potential and the excessive increase of mROS were induced after MGO exposure for 12 h, which were detected by JC-1 or MitoSOX probe. Conclusions MGO reduces cell viability and mitochondria membrane potential in hCMEC/D3 cells with excessive mROS generation.

Key words: diabetic cerebral vascular complication, methylglyoxal, human brain microvascular endothelial cells line, membrane potential, mitochondrial reactive oxygen species

CLC Number:

R364.4

LI Tingting, HAN Zhenping, GAO Li, WANG Siyi, ZHONG Kai, HUANG Ping, YAN Jieping. Methylglyoxal reduces cell viability and mitochondrion membrane potential of human brain microvascular endothelial cell line hCMEC/D3[J]. Basic & Clinical Medicine, 2023, 43(11): 1631-1635.

References 14

[1]	Schalkwijk CG, Stehouwer CDA. Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases[J]. Physiol Rev, 2020, 100: 407-461.
[2]	Stratmann B. Dicarbonyl stress in diabetic vascular disease[J]. Int J Mol Sci, 2022, 23:6186-6200.
[3]	Rabbani N, Thornalley PJ. Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with corroborative prediction in physiological samples[J]. Nat Protoc, 2014, 9: 1969-1979.
[4]	Schalkwijk CG, Micali LR, Wouters K. Advanced glyca-tion endproducts in diabetes-related macrovascular complications: focus on methylglyoxal[J]. Trends Endocrinol Metab, 2023, 34: 49-60.
[5]	胡丽叶,宋光耀,朱旅云,等. 罗格列酮减轻2型糖尿病大鼠血管内皮功能受损[J]. 基础医学与临床, 2017, 37: 1585-1589.
[6]	成永霞,刘贵波,郭素芬,等. AGEs诱发大鼠心脏微血管内皮细胞iNOS表达[J]. 基础医学与临床, 2010, 30: 515-519.
[7]	Wang G, Wang Y, Yang Q, et al. Metformin prevents methylglyoxal-induced apoptosis by suppressing oxidative stress in vitro and in vivo[J]. Cell Death Dis, 2022, 13: 29-40.
[8]	Rabbani N. Methylglyoxal and glyoxalase 1-a metabolic stress pathway-linking hyperglycemia to the unfolded protein response and vascular complications of diabetes[J]. Clin Sci (Lond), 2022, 136: 819-824.
[9]	Kim D, Kim K A, Kim JH, et al. Methylglyoxal-induced dysfunction in brain endothelial cells via the suppression of Akt/HIF-1α pathway and activation of mitophagy associated with increased reactive oxygen species[J]. Antioxidants (Basel), 2020, 9:820-836.
[10]	Yuan J, Zhu C, Hong Y, et al. The role of cPLA2 in methylglyoxal-induced cell apoptosis of HUVECs[J]. Toxicol Appl Pharmacol, 2017, 323: 44-52.
[11]	Wang Y, Hall L M, Kujawa M, et al. Methylglyoxal triggers human aortic endothelial cell dysfunction via modulation of the K(ATP)/MAPK pathway[J]. Am J Physiol Cell Physiol, 2019, 317: 68-81.
[12]	Rabbani N, Thornalley PJ. Emerging glycation-based therapeutics-glyoxalase 1 inducers and glyoxalase 1 inhibitors[J]. Int J Mol Sci, 2022, 23:2453-2472.
[13]	Lee JH, Parveen A, Do MH, et al. Molecular mechani-sms of methylglyoxal-induced aortic endothelial dysfunction in human vascular endothelial cells[J]. Cell Death Dis, 2020, 11: 403-417.
[14]	Li W, Chen Z, Yan M, et al. The protective role of isorhamnetin on human brain microvascular endothelial cells from cytotoxicity induced by methylglyoxal and oxygen-glucose deprivation[J]. J Neurochem, 2016, 136: 651-659.

Methylglyoxal reduces cell viability and mitochondrion membrane potential of human brain microvascular endothelial cell line hCMEC/D3

PDF

Knowledge

Abstract

Cite this article

share this article

References 14

Related Articles 4

Recommended Articles

Metrics

Comments

[1]	YOU Xu, ZHU Xiao-fang, HU Yun-peng, GONG Yang, ZHAO Lei. Effects of total astragalosides on cardiomyocyte apoptosis and mitochondrial membrane potential in rats with heart failure [J]. Basic & Clinical Medicine, 2020, 40(9): 1218-1223.
[2]	SU Jiang-wei, YU Hui, DU Kun, WANG Jie, LIU Lin, CAI Jian. Down-regulation of Notch1 inhibits proliferation and induces apoptosis of fibroblasts from pathological scars [J]. Basic & Clinical Medicine, 2020, 40(3): 328-333.
[3]	. Effects of Resveratrol on Bcl-2/Bax and mitochondrial membrane potential of cells A?1-42 induced HUVECs [J]. Basic & Clinical Medicine, 2016, 36(8): 1108-1112.
[4]	Hong-xian ZHAO; Xia CHEN. Apoptosis and mitochondrial membrane potential change of gastric smooth muscle cells in diabetic rats [J]. Basic & Clinical Medicine, 2009, 29(10): 1083-1086.